zoledronic acid has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bresson-Bepoldin, L; Ducret, T; Latour, S; Pangault, C; Pineau, R; Soubeyran, I; Soubeyran, P; Tarte, K; Vacher, AM; Vacher, P | 1 |
| Arcara, C; Caccamo, N; Di Sano, C; Dieli, F; Fulfaro, F; Gebbia, N; Meraviglia, S; Montesano, C; Poccia, F; Salerno, A; Sireci, G; Valerio, MR | 1 |
2 other study(ies) available for zoledronic acid and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Localized Store-Operated Calcium Influx Represses CD95-Dependent Apoptotic Effects of Rituximab in Non-Hodgkin B Lymphomas.
Topics: Animals; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Calcium; Calcium Channels; Cell Line, Tumor; Diphosphonates; Endoplasmic Reticulum; fas Receptor; Female; HEK293 Cells; Humans; Imidazoles; Lymphoma, Non-Hodgkin; Membrane Proteins; Mice, Knockout; Microscopy, Confocal; Neoplasm Proteins; ORAI1 Protein; Rituximab; RNA Interference; Stromal Interaction Molecule 1; Xenograft Model Antitumor Assays; Zoledronic Acid | 2015 |
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.
Topics: Diphosphonates; Humans; Imidazoles; Lymphoma, Non-Hodgkin; Multiple Myeloma; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Zoledronic Acid | 2003 |